Castle Biosciences’ (CSTL) Overweight Rating Reaffirmed at Stephens
Stephens reissued their overweight rating on shares of Castle Biosciences (NASDAQ:CSTL – Free Report) in a report issued on Thursday morning,Benzinga reports. They currently have a $41.00 target price on the stock. Other analysts have also recently issued research reports about the stock. Canaccord Genuity Group raised their price objective on shares of Castle Biosciences […]
More Stories
Blair William & Co. IL Sells 80 Shares of Mettler-Toledo International, Inc. (NYSE:MTD)
Blair William & Co. IL decreased its position in Mettler-Toledo International, Inc. (NYSE:MTD – Free Report) by 9.5% in the...
US Bancorp DE Sells 2,057 Shares of Pinterest, Inc. (NYSE:PINS)
US Bancorp DE reduced its stake in Pinterest, Inc. (NYSE:PINS – Free Report) by 8.7% during the first quarter, HoldingsChannel.com...
Forecasters Say Tropical Storm Could Develop Over the Next Week
By Jack Phillips U.S. weather forecasters are keeping watch on a storm system that could develop into a tropical storm...
Hims & Hers Health, Inc. (NYSE:HIMS) Shares Acquired by PNC Financial Services Group Inc.
PNC Financial Services Group Inc. lifted its stake in shares of Hims & Hers Health, Inc. (NYSE:HIMS – Free Report)...
Twilio Inc. (NYSE:TWLO) Shares Purchased by PNC Financial Services Group Inc.
PNC Financial Services Group Inc. boosted its holdings in Twilio Inc. (NYSE:TWLO – Free Report) by 8.6% in the first...
Matson, Inc. (NYSE:MATX) Shares Sold by PNC Financial Services Group Inc.
PNC Financial Services Group Inc. lessened its stake in Matson, Inc. (NYSE:MATX – Free Report) by 1.5% in the 1st...